Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Mediphase Venture Partners

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 23
Average round size
info
The average size of a deal this fund participated in
$26M
Portfolio companies 8
Lead investments 3
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.65
Exits 7
Key employees 2
Stages of investment
Early Stage Venture
Late Stage Venture
Private Equity

Areas of investment

  • Health Care
  • Biotechnology
  • Medical
  • Biopharma
  • Pharmaceutical
Summary

The main office of represented VC is situated in the Newton. The fund was located in North America if to be more exact in United States.

The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Mediphase Venture Partners, startups are often financed by Skyline Ventures, New Leaf Venture Partners, Sprout Group. The meaningful sponsors for the fund in investment in the same round are New Leaf Venture Partners, Sprout Group, Skyline Ventures. In the next rounds fund is usually obtained by OrbiMed, New Leaf Venture Partners, 5AM Ventures.

We can highlight the next thriving fund investment areas, such as Medical, Health Care. Among the most popular portfolio startups of the fund, we may highlight Relypsa, Serenex, PatientKeeper. The fund has no exact preference in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.

Besides them, we counted 2 critical employees of this fund in our database.

The top amount of exits for fund were in 2014. The top activity for fund was in 2007. Opposing the other organizations, this Mediphase Venture Partners works on 4 percentage points more the average amount of lead investments. The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 10 - 50 millions dollars. The real fund results show that this VC is 1 percentage points less often commits exit comparing to other companies.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Mediphase Venture Partners:
Typical Co-investors
Mediphase Venture Partners is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Mediphase Venture Partners:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Castik Capital Partners Bayern, Germany, Munich
China Taiping Insurance China, Hong Kong, Hong Kong Island
DECLATEX -
IncSyn Business Incubation Ltd. -
Indies Capital Partners Central, Central Region, Singapore
Linde Material Handling Aschaffenburg, Bayern, Germany
McCombs Enterprises San Antonio, Texas, United States
Modalku East Java, Indonesia, Kebon
Outerwall Bellevue, United States, Washington
Savox Investments -
SG INCUBATE Fukuoka, Fukuoka Prefecture, Japan
Shanghai Huaming Intelligent Terminal Equipment China, Shanghai
Sigma Square Capital Beijing, Beijing, China
Standout Capital Stockholm, Stockholm County, Sweden
Tong Yang Venture Capital Seoul, Seoul-t'ukpyolsi, South Korea
University of Cape Town Gauteng, NA - South Africa, South Africa
VE Partners Amsterdam, Noord-Holland, The Netherlands
Vestech International -
Xiamen ITG Group China, Fujian, Xiamen

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Relypsa

Biopharma
Biotechnology
Health Care
$80M14 Aug 2012 Redwood City, California, United States

Relypsa

Biopharma
Biotechnology
Health Care
$70M08 Aug 2011 Redwood City, California, United States

Relypsa

Biopharma
Biotechnology
Health Care
$70M13 Sep 2010 Redwood City, California, United States

Tetraphase Pharmaceuticals

Biopharma
Biotechnology
Health Care
$45M01 Jun 2010 Massachusetts, United States

Tetraphase Pharmaceuticals

Biopharma
Biotechnology
Health Care
$25M22 Sep 2009 Massachusetts, United States

Tetraphase Pharmaceuticals

Biopharma
Biotechnology
Health Care
$15M07 Aug 2008 Massachusetts, United States

Concert Pharmaceuticals

Biotechnology
Health Care
Medical
$37M30 Apr 2008 Massachusetts, United States

Relypsa

Biopharma
Biotechnology
Health Care
$33M29 Oct 2007 Redwood City, California, United States

Health Care
Medical
Pharmaceutical
$7M27 Mar 2007 Portland, Oregon, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Mediphase Venture Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 23
Average round size 26M
Peak activity year 2010
Lead investments 3
Follow on index 0.65
Exits 7
Group Appearance index 0.96

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Relypsa

Biopharma
Biotechnology
Health Care
$80M14 Aug 2012 Redwood City, California, United States

Relypsa

Biopharma
Biotechnology
Health Care
$70M08 Aug 2011 Redwood City, California, United States

Relypsa

Biopharma
Biotechnology
Health Care
$70M13 Sep 2010 Redwood City, California, United States

Tetraphase Pharmaceuticals

Biopharma
Biotechnology
Health Care
$45M01 Jun 2010 Massachusetts, United States

Tetraphase Pharmaceuticals

Biopharma
Biotechnology
Health Care
$25M22 Sep 2009 Massachusetts, United States

Tetraphase Pharmaceuticals

Biopharma
Biotechnology
Health Care
$15M07 Aug 2008 Massachusetts, United States

Concert Pharmaceuticals

Biotechnology
Health Care
Medical
$37M30 Apr 2008 Massachusetts, United States

Relypsa

Biopharma
Biotechnology
Health Care
$33M29 Oct 2007 Redwood City, California, United States

Health Care
Medical
Pharmaceutical
$7M27 Mar 2007 Portland, Oregon, United States
Crunchbase icon

Content report

The following text will be sent to our editors: